How Congress Crushed the BioTech ETFs

Just like hot stocks, retail investors and institutional investors alike often chase hot ETFs as a momentum play figuring the good fortune will continue. Over the years, we’ve seen certain ETFs based on an asset class or investment theme outperform the market at large only to crash back to earth. During the commodities boom, we […] View the full post at: How Congress Crushed the BioTech ETFs Related posts: ETFs and Panic Avoidance Another Drawback of Exchange Traded Funds (ETFs) Are ETFs A Miracle Cure?